Literature DB >> 30976182

Factors associated with glycemic control in type 2 diabetic patients in Saudi Arabia.

Mansour Almetwazi1,2, Monira Alwhaibi1,2, Bander Balkhi1,2, Hissah Almohaini3, Haya Alturki4, Tariq Alhawassi1,2,3, Sondus Ata3, Nasser AlQahtani5, Mansour Mahmoud6, Thamir Alshammari2,7,5.   

Abstract

OBJECTIVE: To identify factors associated with glycemic control in type 2 diabetes mellitus patients in tertiary academic hospital. RESEARCH DESIGN AND METHODS: This was a retrospective cross-sectional study of adults with type 2 diabetes mellitus. Data were extracted from the electronic health record (EHR) database for the period from 1st of January to 31st of December 2016. Participants were considered to have a glucose control if the HbA1c level was less than 7% [53 mmol/L]. Descriptive analysis and multivariable logistic regression model were performed to assess the factors associated with glycemic control.
RESULTS: A total of 728 patients were included in the study for which (65%) were female, and about 60% of the sample size was between 45 and 60 years old. Multivariate logistic regression model showed participants older than the age of 65 were less likely to have controlled diabetes compared to the younger participants (OR: 0.53 [CI: 0.30-0.93]). Moreover, those who had hypertension (OR: 0.61 [CI: 0.43-0.86]) and dyslipidemia (OR: 0.53 [CI: 0.38-0.74]) were less likely to have controlled diabetes, while those with asthma (OR: 2.06 [CI: 1.16-3.68]) were more likely to have controlled diabetes. The model also showed that vitamin D deficiency was not associated with glycemic control in type 2 diabetes patients (OR 0.80 [95% CI 0.58-1.12]).
CONCLUSION: These findings highlighted the need for appropriate management in older adult patients to prevent the complication of type 2 diabetes. Furthermore, attention should be exercised for patients with factors associated with poor glycemic control such as hypertension and dyslipidemia.

Entities:  

Keywords:  Factors; Saudi Arabia; Type 2 diabetes

Year:  2018        PMID: 30976182      PMCID: PMC6438893          DOI: 10.1016/j.jsps.2018.12.007

Source DB:  PubMed          Journal:  Saudi Pharm J        ISSN: 1319-0164            Impact factor:   4.330


Introduction

Diabetes mellitus (DM) is a major health problem worldwide. It is caused by either not producing insulin, or the body cannot use the insulin adequately, or a combination of these two reasons (Stumvoll et al., 2005). Uncontrolled DM can lead to serious complications such as cerebrovascular disease and coronary heart diseases, blindness, kidney failure and neuropathy diseases (Centers for Disease Control and Prevention, 2017, Zimmet et al., 2001). Prevalence of DM is increased dramatically worldwide. According to the World Health Organization, the prevalence of diabetes in adults increased from 4.7% in 1980 to 8.5% in 2014 (Mathers and Loncar, 2006). In 2017, about 425 million adults had diabetes, and it is estimated to increase to 629 million in 2045 (International Diabetes Federation, 2017). In Saudi Arabia, DM increased from 7% in 1989 to 32% in 2009 (Alharbi et al., 2014). In 2017, there were 3,852,000 cases of diabetes in Saudi Arabia, which places Saudi Arabia globally among the top ten countries in prevalence of diabetes (Alzaheb et al., 2018). The Saudi vision 2030 puts a priority on quality of preventive and therapeutic health care services regarding the major three chronic diseases that threaten the nation health which are heart disease, diabetes, and cancer (Saudi vision 2030, 2018). It is known that achieving glycemic control for patients with diabetes prevents many complications (Kemp et al., 2005, Ong et al., 2008, Stratton et al., 2000). Therefore, understanding the factors associated with glycemic control for patients with diabetes will help to improve the treatment and prevents the complications of diabetes. Many studies have addressed the factors associated with diabetes worldwide (Ahmad et al., 2014, Daly et al., 2009, Juarez et al., 2012, Khattab et al., 2010, Sanal et al., 2011). As the person get older mitochondria activity in muscles and brain is diminished, also fat started to accumulate in muscles and liver tissues leading to a defect in insulin secretion and insulin resistant (Lipska et al., 2016). Co-morbidity and polypharmacy also were found to affect the glycemic control which were increased with the number of chronic disease that the patient had (Teljeur et al., 2013). Vitamin D deficiency is identified as a modifiable factor thought to have a role in glycemic control and insulin secretion from beta cells (Nigil Haroon et al., 2015). However, these factors are different from nation to nation due to differences in lifestyle. In Saudi Arabia, few studies addressed these factors for patient with type 2 diabetes (Abudawood et al., 2018, Al-Nuaim et al., 1998, Alzaheb and Altemani, 2018, Badedi et al., 2016). In those studies, hemoglobin A1C (HbA1c) wasn’t used as an indicator for glycemic control. Moreover, they were limited to a certain population and focused on specific factors. Therefore, the purpose of this cross-sectional study was to explore the factors associated with glycemic control among Saudi population with type 2 diabetes in tertiary academic hospital using HbA1c as indicator of glycemic control.

Methods

Study design

This was a cross-sectional study. Data was extracted from the Electronic Health Record (EHR) of King Khaled University hospital, Riyadh, Saudi Arabia for the period from first January to 31st December 2016. The study was approved by the hospital Institutional Review Board (IRB) protocol number (16/0517/IRB).

Data source and data extraction

Data was exported to excel sheet into multiple files (demographics file, laboratory file, and clinical diagnosis file). The demographics file contained information about the participants’ age and gender. The laboratory file provided information about the level of vitamin D and HbA1c. The clinical diagnosis file provided information about the clinical diagnosis using the International Classifications of Diseases – 9th edition, Clinical Modification (ICD-9-CM) codes. After extracting the data from each file, multiple observations for one participant each with different diagnosis (e.g. Hypertension, Dyslipidemia, T2DM) were converted to one observation to facilitate the analysis and prevent the duplication of the same participant. The demographics, laboratory, and clinical diagnosis files were merged into one file using the encrypted participant medical record number.

Study population

The study population composed of adult participant who had a diagnosis of type 2 diabetes (T2DM). Participants whose HbA1c were missing and those whose ages were less than 18 years were excluded.

Measures

Dependent variable

The dependent variable of this study was glycemic control. Participants were considered having controlled diabetes if their HbA1c was less than 7% according to the American Diabetes Association’s (ADA) Standards of Care recommendation. (American Diabetes Association, “6. Glycemic Targets: Standards of Medical Care in Diabetes,” 2018).

Independent variable

Independent variables included age groups (young adults [aged 18–44], middle age adults [ages 45–64], and older adults [>65 years]), and diagnosed chronic conditions (hypertension, dyslipidemia, ischemic heart disease, chronic kidney disease, asthma, osteoarthritis, osteoporosis, anxiety, and depression). These conditions were selected because they are highly prevalent among participants with diabetes (Teljeur et al., 2013, Iglay et al., 2016). For vitamin D, the participants were divided into two groups. The first group consisted of participants with serum vitamin D more than 50 nmol/L (non-vitamin D deficiency). The second group consisted of participants with serum vitamin D < 50 nmol/L (vitamin D deficiency).(Bordelon et al., 2009).

Statistical analysis

Descriptive analyses and chi square were conducted to describe the study population. A multivariable logistic regression model was used to predict the relationship between glycemic control (HbA1c < 7% [53 mmol/L]) and vitamin D deficiency. Odds ratios and 95% confidence intervals were used to present the results, and a P value < 0.05 was considered statistically significant. All the statistical analyses were performed using Stata/SE 13.1.

Results

A total of 728 patients were screened and were found eligible for the study. Demographics and co-morbidities characteristics presented in Table 1. Middle age adults (45–64 years) represents (59.62%) of the studied population and (65%) of them were female. Hypertension and dyslipidemia were the most prevalent comorbidities in the study sample. There were (7.83%) patients with anxiety and (1.51%) with depression. Sixty-seven patients from the study sample had asthma (9%). Chronic kidney disease and ischemic heart disease were the least reported comorbidities.
Table 1

Demographic and co-morbidities characteristics.

CharacteristicControlled DM 56.87% (414)Uncontrolled DM 43.13% (314)Totalp- value chi square
Vitamin D deficiency
Yes18.82% (137)15.11% (110)33.93% (247)0.584
No38.05% (277)28.02% (204)66.07% (481)



Gender
Male20.74% (151)14.42% (105)35.16% (256)0.396
Female36.13% (263)28.71% (209)64.84% (472)



Age
Young adults (18–44 years)17.03% (124)7.14% (52)24.18% (176)<0.001*
Middle age adults (45–64 years)32.55% (237)27.06% (197)59.62% (434)
Older adults (>65 years)7.28% (53)8.93% (65)16.21% (118)



Hypertension
Yes26.37% (192)28.16% (205)54.53% (397)<0.001*
No30.49% (222)14.97% (109)45.47% (331)



Dyslipidemia
Yes25.41% (185)27.88% (203)53.30% (388)<0.001*
No31.46% (229)15.25% (111)46.70% (340)



Ischemic heart disease
Yes0.41% (3)0.96% (7)1.37% (10)0.084
No56.46% (411)42.17% (307)98.63% (718)



Chronic kidney disease
Yes0.41% (3)0.69% (5)1.10% (8)0.266
No56.46% (411)42.45% (309)98.90% (720)



Asthma
Yes6.59% (48)2.61% (19)9.20% (67)0.010*
No50.27% (366)40.52% (295)90.80% (661)



Osteoarthritis
Yes3.02% (22)2.75% (20)5.77% (42)0.545
No53.85% (392)40.38% (294)94.23% (686)



Osteoporosis
Yes2.43% (17)1.51% (11)3.85% (28)0.675
No54.53% (397)41.62% (303)96.15% (700)



Anxiety
Yes5.63% (41)2.20% (16)7.83% (57)0.017*
No51.24% (373)40.93% (298)92.17% (671)



Depression
Yes0.82% (6)0.69% (5)1.51% (11)0.875
No56.04% (408)42.45% (309)98.49% (717)

Statistical significant.

Demographic and co-morbidities characteristics. Statistical significant. The results of multivariable logistic regression that showed in Table 2 revealed that patients with vitamin D deficiency were less likely to have controlled diabetes compared to those without vitamin D deficiency. Participants older than age of 65 were less likely to have controlled diabetes compared to the younger participants (Odds Ratio (OR): 0.53 [CI: 0.30–0.93]). Those who had hypertension (OR:0.61 [CI: 0.43–0.86]) and dyslipidemia (OR:0.53 [CI: 0.38–0.74]) were less likely to have controlled diabetes while those who had asthma (OR: 2.06 [CI: 1.16–3.68]) were more likely to have controlled diabetes. Other factors such as gender, osteoporosis, osteoarthritis, anxiety, ischemic heart disease, chronic kidney disease and depression were not significant.
Table 2

Results of the logistic regression, for the effect of vitamin D deficiency in diabetic control.

VariablesAdjusted odds ratio (95%)p- value
Vitamin D deficiency
Non-deficientReference
Deficient0.80 [CI: 0.58–1.12]0.212



Gender
FemaleReference
Male1.03 [CI: 0.74–1.44]0.825



Age
Young adults (18–44 years)Reference
Middle age adults (45–64 years)0.72 [CI: 0.47–1.10]0.134
Older adults (>65 years)0.53 [CI: 0.30–0.93]0.028*



Hypertension
NoReference
Yes0.61 [CI: 0.43–0.86]0.006*



Dyslipidemia
NoReference
Yes0.53 [CI: 0.38–0.74]0.000*



Ischemic heart disease
NoReference
Yes0.41 [CI: 0.10–1.69]0.220



Chronic kidney disease
NoReference
Yes0.49 [CI: 0.10–2.28]0.364



Asthma
NoReference
Yes2.06 [CI: 1.16–3.68]0.013*



Osteoarthritis
NoReference
Yes1.08 [CI: 0.56–2.09]0.803



Osteoporosis
NoReference
Yes1.88 [CI: 0.81–4.32]0.136



Anxiety
NoReference
Yes1.53 [CI: 0.81–2.9]0.186



Depression
NoReference
Yes0.98 [CI: 0.28–3.44]0.985

Statistical significant.

Results of the logistic regression, for the effect of vitamin D deficiency in diabetic control. Statistical significant.

Discussion

The study assessed the factors that are associated with uncontrolled type 2 diabetes among patients in a tertiary academic hospital. The study used HbA1c as an indicator of controlled and uncontrolled diabetes because it gives an overall picture of the blood glucose level during the last three months. One of these factors is vitamin D level which is essential to increase absorption of calcium ion from gastrointestinal tract which plays a major role in insulin secretion (Sung et al., 2012). The results indicated that one third of diabetic population from the study sample had vitamin D deficiency. Based on a recent meta-analysis study, about 63% of a Saudi population had vitamin D deficiency, which is double of this study results in diabetic patients (Al-Alyani et al., 2018). This could be attributed to the fact that we only restrict this study to adult patients who used non-insulin therapy. A previous study that was done in diabetic (type 1 and type 2) in the United States population had the same results (Almetwazi et al., 2017). This indicated correction of vitamin D is less likely to have an impact on controlling diabetes. One of the factors that were found to be associated with uncontrolled diabetes in this study was being an older adult. Based on the American Diabetes Association, about one-quarter of the population above 65 years old have diabetes, and nearly half of the them have prediabetes (American Diabetes Association, “11. Older Adults: Standards of Medical Care in Diabetes-2018,” 2018). The results indicated that non-insulin user of type 2 diabetic patients older than 65 years were more likely to be glycemically uncontrolled compared to young adult. This result is expected due to the fact that this category of patients is at high risk of using multiple medications (polypharmacy), or having cognitive impairment, urinary incontinence, injurious falls, and persistent pain (American Diabetes Association, “11. Older Adults: Standards of Medical Care in Diabetes-2018,” 2018). Therefore, it is highly recommended to monitor and follow up with this age category to slow the progression of diabetes and improve the quality of life of these patients. Hypertension and dyslipidemia have been found to be associated with uncontrolled diabetes in this study. Although it is known that these three diseases increased the risk of morbidity and mortality from cardiovascular events, yet our patient who have hypertension or dyslipidemia tend to have uncontrolled diabetes (Ferrannini and Cushman, 2012, Mooradian, 2009). Moreover, some medications that are used to treat hypertension such as thiazide diuretic, and statin that are used to treat dyslipidemia may contribute to these results (Maki et al., 2015, Stears et al., 2012). Interestingly, the result indicated that patients who have asthma were more likely to have controlled diabetes. Although previous review study revealed that asthma is associated with diabetes diseases, no previous study found an association between asthma and diabetic control (Cazzola et al., 2013). Lastly, other diseases that were included in this study were found to be not associated with glycemic control. These diseases are osteoporosis, osteoarthritis, anxiety, ischemic heart disease, chronic kidney disease and depression. Future studies with a large number of patients are needed to determine the association of these disease with glycemic control. The sample of the study was taken from one largely academic hospital with which covers local citizens as well as residents, from the middle region of Saudi Arabia; the hospital also serves the entire country as a referral center. Therefore, finding of this study could be generalized to all local and foreign residence groups living in Saudi Arabia. Cross-sectional design is considering one of the limitations of this study. Future studies with different design and more variables are needed.

Conclusion

In conclusion, the study findings showed that advanced age is one of the main factors affecting glycemic control. Therefore, an appropriate management and close monitoring is advised to limit disease complications and improve the patients’ health. Moreover, attention should be paid for patients with factors associated with poor glycemic control such as hypertension and dyslipidemia.
  27 in total

1.  Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.

Authors:  I M Stratton; A I Adler; H A Neil; D R Matthews; S E Manley; C A Cull; D Hadden; R C Turner; R R Holman
Journal:  BMJ       Date:  2000-08-12

2.  Glucose, lipid, and blood pressure control in Australian adults with type 2 diabetes: the 1999-2000 AusDiab.

Authors:  Thomas M Kemp; Elizabeth L M Barr; Paul Z Zimmet; Adrian J Cameron; Timothy A Welborn; Stephen Colagiuri; Patrick Phillips; Jonathan E Shaw
Journal:  Diabetes Care       Date:  2005-06       Impact factor: 19.112

Review 3.  Global and societal implications of the diabetes epidemic.

Authors:  P Zimmet; K G Alberti; J Shaw
Journal:  Nature       Date:  2001-12-13       Impact factor: 49.962

Review 4.  Type 2 diabetes: principles of pathogenesis and therapy.

Authors:  Michael Stumvoll; Barry J Goldstein; Timon W van Haeften
Journal:  Lancet       Date:  2005 Apr 9-15       Impact factor: 79.321

5.  Prevalence, treatment, and control of diagnosed diabetes in the U.S. National Health and Nutrition Examination Survey 1999-2004.

Authors:  Kwok Leung Ong; Bernard M Y Cheung; Louisa Y F Wong; Nelson M S Wat; Kathryn C B Tan; Karen S L Lam
Journal:  Ann Epidemiol       Date:  2008-01-16       Impact factor: 3.797

6.  Factors associated with poor glycemic control among patients with type 2 diabetes.

Authors:  Maysaa Khattab; Yousef S Khader; Abdelkarim Al-Khawaldeh; Kamel Ajlouni
Journal:  J Diabetes Complications       Date:  2009-03-17       Impact factor: 2.852

7.  An assessment of attitudes, behaviors, and outcomes of patients with type 2 diabetes.

Authors:  Jeanette M Daly; Arthur J Hartz; Yinghui Xu; Barcey T Levy; Paul A James; Mary L Merchant; Robert E Garrett
Journal:  J Am Board Fam Med       Date:  2009 May-Jun       Impact factor: 2.657

Review 8.  Dyslipidemia in type 2 diabetes mellitus.

Authors:  Arshag D Mooradian
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2009-03

9.  Pattern and factors associated with glycemic control of Saudi diabetic patients.

Authors:  A R Al-Nuaim; S Mirdad; K Al-Rubeaan; Y Al-Mazrou; O Al-Attas; N Al-Daghari
Journal:  Ann Saudi Med       Date:  1998 Mar-Apr       Impact factor: 1.526

10.  Projections of global mortality and burden of disease from 2002 to 2030.

Authors:  Colin D Mathers; Dejan Loncar
Journal:  PLoS Med       Date:  2006-11       Impact factor: 11.069

View more
  7 in total

1.  Relation of Hypoxia Inducible Factor, Dyslipidemia and CAD Saudi Patients With Type 2 Diabetes.

Authors:  Amal F Gharib; Taisir Saber; Ahmad El Askary; Afaf Alharthi; Nouf Ali Alsalmi; Saja Talal Alhashmi; Rana Fawaz Al-Asiri; Alaa Shafie
Journal:  In Vivo       Date:  2022 Sep-Oct       Impact factor: 2.406

2.  Knowledge, Attitudes, and Practices Regarding Diabetes Mellitus Among University Students in Jeddah, Saudi Arabia.

Authors:  Zohair J Gazzaz
Journal:  Diabetes Metab Syndr Obes       Date:  2020-12-23       Impact factor: 3.168

3.  Factors Associated with Glycaemic Control among Diabetic Patients Managed at an Urban Hospital in Hanoi, Vietnam.

Authors:  Luu Quang Thuy; Hoang Thi Phuong Nam; Tran Thi Ha An; Bui Van San; Tran Nguyen Ngoc; Le Hong Trung; Pham Huy Tan; Nguyen Hoang Thanh
Journal:  Biomed Res Int       Date:  2021-02-24       Impact factor: 3.411

Review 4.  Glycaemic control and its associated factors in patients with type 2 diabetes in the Middle East and North Africa: An updated systematic review and meta-analysis.

Authors:  Odai Hamed Al-Ma'aitah; Daniel Demant; Samantha Jakimowicz; Lin Perry
Journal:  J Adv Nurs       Date:  2022-05-27       Impact factor: 3.057

5.  Illness Perceptions, HbA1c, And Adherence In Type 2 Diabetes In Saudi Arabia.

Authors:  Mohsen Alyami; Anna Serlachius; Ibrahim Mokhtar; Elizabeth Broadbent
Journal:  Patient Prefer Adherence       Date:  2019-10-25       Impact factor: 2.314

6.  Knowledge of chronic complications of diabetes among persons living with type 2 diabetes mellitus in northern Ghana.

Authors:  Richard Adongo Afaya; Victoria Bam; Thomas Bavo Azongo; Agani Afaya
Journal:  PLoS One       Date:  2020-10-28       Impact factor: 3.240

7.  The effect of comorbidities on glycemic control among Colombian adults with diabetes mellitus: a longitudinal approach with real-world data.

Authors:  Manuel Urina-Jassir; Lina Johana Herrera-Parra; Juliana Alexandra Hernández Vargas; Ana María Valbuena-García; Lizbeth Acuña-Merchán; Miguel Urina-Triana
Journal:  BMC Endocr Disord       Date:  2021-06-26       Impact factor: 2.763

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.